To,

July 29, 2021

National Stock Exchange of India Limited

Exchange Plaza, Bandra Kurla Complex,

Bandra (East),

Mumbai - 400 051

Scrip Code: JYOTHYLAB

BSE Limited

Phiroze Jeejeebhoy Towers,

Dalal Street,

Mumbai - 400 023

Scrip Code: 532926

Dear Sir,

Sub: Outcome of the Board Meeting held on July 29, 2021

Further to our letter dated July 21, 2021 on the captioned subject, we wish to inform you that the Board of Directors of the Company at its meeting held today at 11:00 a.m. and concluded at 1:00 p.m., approved the Un-audited Financial Results on Standalone and Consolidated basis for the quarter ended June 30, 2021 with Limited Review by the Statutory Auditors of the Company.

Accordingly, in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the Un-audited Financial Results on Standalone and Consolidated basis for the quarter ended June 30, 2021 accompanied with the Limited Review Report by the Statutory Auditors of the Company.

Also attached is the Press Release by the Company in respect of its performance during the quarter ended June 30, 2021.

Kindly take the above on your record and disseminate the same for the information of investors.

Thanking you,

Yours faithfully,

For Jyothy Labs Limited

(Formerly known as Jyothy Laboratories Limited)

Shreyas Trivedi

Head - Legal & Company Secretary

Encl.: as above

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Jyothy Laboratories Limited published this content on 29 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 July 2021 08:06:04 UTC.